AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimizone M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Carezone Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimizone M 1mg/500mg Tablet SR

Diabetam SR 1mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This formulation helps regulate blood glucose levels. Diabetam SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, it's a component of a comprehensive diabetes management plan, encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are paramount in diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by sweating, dizziness, headaches, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal dysfunction. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests assessing blood cell counts and liver function, are recommended.

Uses of Glimizone M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimizone M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. Glimizone M 1mg/500mg Sustained-Release tablets should be taken with meals.

Common Side effects of Glimizone M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimizone M 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Glimizone M 1mg/500mg Extended-Release tablets with food.

How Glimizone M 1mg/500mg Tablet SR works:

Glimepiride and Metformin, combined as Glimizone M 1mg/500mg sustained-release tablets, offer dual action against high blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose uptake, and enhances insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimizone M 1mg/500mg SR tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimizone M 1mg/500mg tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against the risks before prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Extended-release Glimizone M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimizone M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Glimizone M 1mg/500mg SR tablets are contraindicated in those with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

The extended-release Glimizone M 1mg/500mg tablet requires careful administration in individuals with hepatic impairment. Dosage modification of Glimizone M 1mg/500mg Tablet SR may be necessary. Physician consultation is advised. For patients experiencing mild to moderate liver dysfunction, Glimizone M 1mg/500mg Tablet SR is typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimizone M 1mg/500mg Tablet SR :

Should you forget a Glimizone M 1mg/500mg SR tablet, take it immediately upon remembering. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Glimizone M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimizone M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication safely, ensuring it's inaccessible to children, pets, and others.
Glimizone M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimizone M 1mg/500mg Tablet SR and seek immediate medical attention.
Glimizone M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimizone M 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimizone M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimizone M 1mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimizone M 1mg/500mg SR tablets with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimizone M 1mg/500mg Tab...
45
MRP 55
18% off